Immediate Impact
50 standout
Citing Papers
Advances in diagnosis and treatment of bladder cancer
2024 Standout
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
2023 Standout
Works of Michael Hutchison being referenced
ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells
2000
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Hutchison | 94 | 47 | 57 | 86 | 15 | 257 | |
| P. Peng | 37 | 7 | 44 | 80 | 20 | 298 | |
| J. Cairns | 50 | 4 | 72 | 85 | 12 | 310 | |
| Claudia Zaharia | 52 | 27 | 146 | 20 | 25 | 285 | |
| Sayed Obaidullah Aseem | 26 | 16 | 32 | 74 | 21 | 298 | |
| Lanying Zhao | 29 | 22 | 45 | 121 | 20 | 315 | |
| Michèle de Saint Laurent | 42 | 44 | 190 | 17 | 24 | 315 | |
| Xiaojun Feng | 18 | 9 | 57 | 97 | 21 | 320 | |
| Qiyong Zhang | 54 | 145 | 49 | 86 | 16 | 296 | |
| Phil Harrison | 66 | 15 | 48 | 16 | 10 | 263 | |
| Thomas Olin | 25 | 84 | 39 | 111 | 28 | 300 |
All Works
Login with ORCID to disown or claim papers
Loading papers...